查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1479938

甘露醇市场 - 2024 年至 2029 年预测

Mannitol Market - Forecasts from 2024 to 2029
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 139 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

甘露醇市场预计复合年增长率为 4.24%，从 2022 年的 517,442,000 美元市场规模到 2029 年达到 692,055,000 美元。

甘露醇是一种糖醇或糖醇，具有低溶解度和吸湿性，既可用作甜味剂，也可用作药物。甘露醇天然存在于树皮、新鲜菇类、褐藻、海藻以及大多数水果和蔬菜中。某些疾病的盛行率不断上升、生活方式更加活跃以及所有地区的人口不断增长预计将对市场产生积极影响。该产品在製药工业中用作治疗肾臟疾病、脑病和心臟病以及配製药物的赋形剂。此外，它也用作压片应用的填充剂。

消费者生活品质的显着改善主要得益于个人收入的增加。随着消费者健康意识的增强，人们的饮食习惯正在发生显着变化。此外，公司正在投入更多的时间和资源来开发由天然成分製成的产品和专门为促进健康而设计的产品。因此，对低热量天然甜味剂的需求不断增长正在推动预测期内全球甘露醇市场的成长。糖尿病人口的成长也推动了扩张，因为甘露醇对消费者的血糖值几乎没有影响。

扩大甘露醇作为人造甜味剂的使用

市场扩张的一个主要因素是甘露醇作为食品添加剂和人工甜味剂的使用量不断增加。甘露醇使血糖值远低于蔗糖。因此，更多的产品被用于糖尿病饮食。此外，随着肥胖和糖尿病的发病率增加，人们开始转向更健康的食品，从而促进了市场的扩张。此外，由于甘露醇用于奶油、冷冻鱼、已烹调义式麵食和婴儿配方奶粉等产品，对甘露醇的需求也在增加。此外，随着饮食习惯的改变和人们健康意识的增强，消费者越来越偏好低食品和零热量食品，导致对人造甜味剂的需求增加。

食品和饮料行业的需求不断增长

甘露醇在多种糖果零食製品中用作甜味剂，特别是砂糖产品。由于其溶解度低、潜热高，甘露醇广泛用于薄荷糖和泡泡糖的生产。甘露醇吸湿性极低，在湿度达到98%之前不会吸收空气中的水分，非常适合用作硬糖、干果、巧克力涂层、口香糖等的涂层。甘露醇优异的风味和质地使其成为咀嚼锭的首选赋形剂。

甘露醇的升糖指数比蔗糖低，是糖尿病患者的甜味剂。因此，肥胖、糖尿病、METABOLIC INC.症候群患者数量的增加以及消费者意识的提高正在导致甘露醇的积极扩张。

慢性病增加

甘露醇市场预计将主要受到导致糖尿病和其他心血管疾病的慢性病盛行率上升的推动。此外，糖尿病患者数量的增加以及适应各种无糖产品选择的意愿将推动甘露醇市场的发展。此外，根据世界卫生组织(WHO)称，全球有4.22亿人患有糖尿病，主要分布在低收入和中等收入国家，该疾病每年直接导致160万人死亡。

甘露醇的热量比低热量食品常见的碳水化合物少。甘露醇无需胰岛素即可消化，因此适合糖尿病患者饮食。随着糖尿病患者数量的增加，对低糖、低热量产品的需求不断增加。随着人们越来越认识到食用低热量砂糖有益于健康，预计未来几年对甘露醇的需求将增加，并且市场预计在预测期内扩大。

製药业的高需求

由于利尿剂、药片锭剂以及心臟疾病、肺部和肾衰竭治疗等用途的扩大，市场正在扩大。另外，由于其吸湿性低，具有清凉作用，已被用于口香糖、薄荷味糖果、咀嚼片等产品中，且市场不断扩大。其他因素，例如该产品在烘焙和糖果零食中的采用增加、在压片应用中作为填充剂的使用增加、持续的研发 (R&D) 活动以及持续的技术进步也有助于我们支持市场的积极前景。 。

亚太地区在预测期内将经历指数级增长

预计亚太地区将占据甘露醇的巨大市场占有率。由于消费者健康意识的增强、都市化程度的提高和可支配收入的增加，预计该地区在预测期内将出现高速成长。甘露醇在中国和印度等新兴市场的需求量大。由于饮食习惯的改变以及对低热量产品和饮料的需求不断增加，该地区的市场正在扩大。甘露醇不会影响血糖值，使其成为糖尿病患者的绝佳选择。因此，印度和中国等国家糖尿病盛行率的上升正在推动这一领域的需求。

主要市场产品

  • 2022 年 11 月，领先的製药和营养补充食品製造商罗盖特 (Roquette) 宣布推出两种用于直接压片的下一代甘露醇解决方案：Pearitol CR-H 和 Pearlitol 200 GT。这两种赋形剂都是专门为解决製药行业独特的配方挑战而开发的，可帮助製造商优化直接压片技术并实现控制释放锭剂和微型片剂等创新，并正在扩展到各种应用领域。

目录

第一章简介

  • 市场概况
  • 市场定义
  • 调查范围
  • 市场区隔
  • 货币
  • 先决条件
  • 基准年和预测年时间表
  • 相关利益者的主要利益

第二章调查方法

  • 研究设计
  • 调查过程

第三章执行摘要

  • 主要发现
  • 分析师观点

第四章市场动态

  • 市场驱动因素
  • 市场限制因素
  • 波特五力分析
  • 产业价值链分析
  • 分析师观点

第五章甘露醇市场：依形式

  • 介绍
  • 粉末
  • 颗粒

第六章 甘露醇市场：依应用分类

  • 介绍
  • 食品
  • 药品
  • 产业
  • 其他的

第七章甘露醇市场：依地区

  • 介绍
  • 北美洲
    • 按形式
    • 按用途
    • 按国家/地区
  • 南美洲
    • 按形式
    • 按用途
    • 按国家/地区
  • 欧洲
    • 按形式
    • 按用途
    • 按国家/地区
  • 中东/非洲
    • 按形式
    • 按用途
    • 按国家/地区
  • 亚太地区
    • 按形式
    • 按用途
    • 按国家/地区

第八章竞争环境及分析

  • 主要企业及策略分析
  • 市场占有率分析
  • 合併、收购、协议和合作
  • 竞争对手仪表板

第九章 公司简介

  • Roquette Freres Company
  • Cargill, Incorporated.
  • Ingredion Incorporated
  • SPI Pharm
  • Singsino Group Ltd.,
  • Merck Millipore Corporation
  • Bright Moon Seaweed
简介目录
Product Code: KSI061615253

The mannitol market is expected to grow at a CAGR of 4.24% reaching a market size of US$692.055 million in 2029 from US$517.442 million in 2022.

Mannitol is a type of sugar polyol or sugar alcohol with low solubility and hygroscopicity and is used as both a sweetener and a drug. Mannitol is naturally found in tree bark, fresh mushrooms, brown algae, seaweed, and most fruits and vegetables. Increased prevalence of certain diseases, a more dynamic lifestyle, and growing populations in all regions are expected to have a positive effect on the market. This product is used as an excipient in the pharmaceutical industry to treat kidney, brain, and heart diseases as well as to formulate pharmaceutical products. Additionally, it is employed in tableting applications as a bulking agent.

The consumer's quality of life has greatly improved, owing mostly to increased personal income. As a result of rising health consciousness among consumers, the population's eating habits have shifted substantially. Furthermore, firms are investing a lot of time and resources in developing products composed of natural ingredients and specialized goods that improve health. As a result, rising demand for low-calorie natural sweeteners is propelling the growth of the global market for mannitol throughout the projected period. The growing diabetic population is also driving expansion since mannitol has little to no effect on the consumer's blood sugar level.

Increasing application of mannitol as an artificial sweetener

The main driver of the market expansion is the growing use of mannitol as a food additive and artificial sweetener. Mannitol causes a much smaller rise in blood sugar when compared to sucrose. Consequently, more products are being used in diabetic food. In addition, there has been a noticeable shift toward healthier food options as a result of the growing rates of obesity and diabetes, which is helping the market expand. In addition, the demand for the product has increased due to the increasing use of mannitol in butter, frozen fish, pre-cooked pasta, and baby formula. Furthermore, as dietary habits change and health consciousness rises, consumers' preferences for low- and zero-calorie foods are growing, which has increased the demand for artificial sweeteners.

Increasing demand in food & beverages industry

Mannitol is used as a sweetener in various confectionary goods, especially sugar-free products. Due to low solubility and high latent heat, mannitol is extensively used to produce mint candies and bubble gums. It has a very low hygroscopicity, meaning that it does not absorb water from the air until the humidity level reaches 98 percent, which makes it an excellent covering for hard candies, dried fruits, chocolate coatings, and chewing gums. Mannitol's excellent flavour and texture make it a preferred excipient for chewable tablets.

Mannitol has a lower glycemic index than sucrose and is a sweetener for diabetic patients. Therefore, an increasing number of cases of obesity, diabetes, and metabolic syndrome, along with improved consumer awareness, has resulted in a positive expansion of mannitol.

Increasing cases of chronic diseases

The market for mannitol is expected to be driven primarily by the rising prevalence of chronic diseases, which can lead to diabetes and other cardiovascular diseases. Furthermore, the growing number of diabetes patients and their willingness to adjust to various sugar-free product options will drive the market for mannitol. Furthermore, 422 million people worldwide, mostly in low- and middle-income nations, have diabetes, according to the World Health Organization, and the disease is directly responsible for 1.6 million deaths annually.

Compared to carbohydrates, which are frequently used in low-calorie foods, mannitol has fewer calories. Mannitol is a good option for diabetic diets because it can be digested without the need for insulin. The demand for low-sugar and low-calorie products is rising in tandem with the rise in the number of patients with diabetes. People's awareness of the health benefits of consuming low-calorie sugar is expected to increase demand for mannitol in the upcoming years, and the market is expected to grow during the forecast period.

High demand from the pharmaceutical industry

The market has grown as a result of the expanding uses of the product, which include diuretics, excipients in pharmaceutical tablets, and the treatment of heart and lung conditions as well as renal failure. Accordingly, the market has grown as a result of the increasing use of mannitol in chewing gum, mint-flavored candies, and chewable tablets due to its low hygroscopicity and cooling effect. A positive market outlook is also being fueled by other factors, such as growing product adoption in bakery and confectionery items, growing use as a bulking agent for tableting applications, continuing research and development (R&D) activities, and ongoing technological advancements.

Asia Pacific is witnessing exponential growth during the forecast period

Asia Pacific region is anticipated to hold a significant market share in mannitol. This region will witness high growth during the forecast period due to the rising health copiousness among consumers, increased urbanization, and rising disposable income. Mannitol is in high demand in rising markets such as China and India. This region's market is expanding due to changing eating habits and rising demand for low-calorie products and drinks. Mannitol does not affect blood sugar levels, making them an excellent choice for diabetic individuals. As a result, increased diabetes incidence in countries such as India and China is driving demand in this area

Market key launches

  • In November 2022, Roquette, a major pharmaceutical and nutraceutical excipients manufacturer, introduced two next-generation mannitol solutions for direct compression: Pearlitol CR-H and Pearlitol 200 GT. Both excipients were created specifically to address unique drug formulation issues in the pharmaceutical industry, assisting manufacturers in optimizing direct compression techniques and expanding into innovative application areas such as controlled-release tablets and tiny tabs.

Segmentation:

By Form

  • Powder
  • Granules

By Application

  • Food
  • Pharmaceuticals
  • Industrial
  • Others

By Geography

  • North America
  • United States
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • United Kingdom
  • Germany
  • France
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Others
  • Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Indonesia
  • Thailand
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base, and Forecast Years Timeline
  • 1.8. Key Benefits to the Stakeholder

2. RESEARCH METHODOLOGY

  • 2.1. Research Design
  • 2.2. Research Processes

3. EXECUTIVE SUMMARY

  • 3.1. Key Findings
  • 3.2. Analyst View

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis
  • 4.5. Analyst View

5. MANNITOL MARKET, BY FORM

  • 5.1. Introduction
  • 5.2. Powder
    • 5.2.1. Market Trends and Opportunities
    • 5.2.2. Growth Prospects
    • 5.2.3. Geographic Lucrativeness
  • 5.3. Granules
    • 5.3.1. Market Trends and Opportunities
    • 5.3.2. Growth Prospects
    • 5.3.3. Geographic Lucrativeness

6. MANNITOL MARKET, BY APPLICATION

  • 6.1. Introduction
  • 6.2. Food
    • 6.2.1. Market Trends and Opportunities
    • 6.2.2. Growth Prospects
    • 6.2.3. Geographic Lucrativeness
  • 6.3. Pharmaceuticals
    • 6.3.1. Market Trends and Opportunities
    • 6.3.2. Growth Prospects
    • 6.3.3. Geographic Lucrativeness
  • 6.4. Industrial
    • 6.4.1. Market Trends and Opportunities
    • 6.4.2. Growth Prospects
    • 6.4.3. Geographic Lucrativeness
  • 6.5. Others
    • 6.5.1. Market Trends and Opportunities
    • 6.5.2. Growth Prospects
    • 6.5.3. Geographic Lucrativeness

7. MANNITOL MARKET, BY GEOGRAPHY

  • 7.1. Introduction
  • 7.2. North America
    • 7.2.1. By Form
    • 7.2.2. By Application
    • 7.2.3. By Country
      • 7.2.3.1. United States
        • 7.2.3.1.1. Market Trends and Opportunities
        • 7.2.3.1.2. Growth Prospects
      • 7.2.3.2. Canada
        • 7.2.3.2.1. Market Trends and Opportunities
        • 7.2.3.2.2. Growth Prospects
      • 7.2.3.3. Mexico
        • 7.2.3.3.1. Market Trends and Opportunities
        • 7.2.3.3.2. Growth Prospects
  • 7.3. South America
    • 7.3.1. By Form
    • 7.3.2. By Application
    • 7.3.3. By Country
      • 7.3.3.1. Brazil
        • 7.3.3.1.1. Market Trends and Opportunities
        • 7.3.3.1.2. Growth Prospects
      • 7.3.3.2. Argentina
        • 7.3.3.2.1. Market Trends and Opportunities
        • 7.3.3.2.2. Growth Prospects
      • 7.3.3.3. Others
        • 7.3.3.3.1. Market Trends and Opportunities
        • 7.3.3.3.2. Growth Prospects
  • 7.4. Europe
    • 7.4.1. By Form
    • 7.4.2. By Application
    • 7.4.3. By Country
      • 7.4.3.1. United Kingdom
        • 7.4.3.1.1. Market Trends and Opportunities
        • 7.4.3.1.2. Growth Prospects
      • 7.4.3.2. Germany
        • 7.4.3.2.1. Market Trends and Opportunities
        • 7.4.3.2.2. Growth Prospects
      • 7.4.3.3. France
        • 7.4.3.3.1. Market Trends and Opportunities
        • 7.4.3.3.2. Growth Prospects
      • 7.4.3.4. Spain
        • 7.4.3.4.1. Market Trends and Opportunities
        • 7.4.3.4.2. Growth Prospects
      • 7.4.3.5. Others
        • 7.4.3.5.1. Market Trends and Opportunities
        • 7.4.3.5.2. Growth Prospects
  • 7.5. Middle East and Africa
    • 7.5.1. By Form
    • 7.5.2. By Application
    • 7.5.3. By Country
      • 7.5.3.1. Saudi Arabia
        • 7.5.3.1.1. Market Trends and Opportunities
        • 7.5.3.1.2. Growth Prospects
      • 7.5.3.2. UAE
        • 7.5.3.2.1. Market Trends and Opportunities
        • 7.5.3.2.2. Growth Prospects
      • 7.5.3.3. Israel
        • 7.5.3.3.1. Market Trends and Opportunities
        • 7.5.3.3.2. Growth Prospects
      • 7.5.3.4. Others
        • 7.5.3.4.1. Market Trends and Opportunities
        • 7.5.3.4.2. Growth Prospects
  • 7.6. Asia Pacific
    • 7.6.1. By Form
    • 7.6.2. By Application
    • 7.6.3. By Country
      • 7.6.3.1. Japan
        • 7.6.3.1.1. Market Trends and Opportunities
        • 7.6.3.1.2. Growth Prospects
      • 7.6.3.2. China
        • 7.6.3.2.1. Market Trends and Opportunities
        • 7.6.3.2.2. Growth Prospects
      • 7.6.3.3. India
        • 7.6.3.3.1. Market Trends and Opportunities
        • 7.6.3.3.2. Growth Prospects
      • 7.6.3.4. South Korea
        • 7.6.3.4.1. Market Trends and Opportunities
        • 7.6.3.4.2. Growth Prospects
      • 7.6.3.5. Indonesia
        • 7.6.3.5.1. Market Trends and Opportunities
        • 7.6.3.5.2. Growth Prospects
      • 7.6.3.6. Thailand
        • 7.6.3.6.1. Market Trends and Opportunities
        • 7.6.3.6.2. Growth Prospects
      • 7.6.3.7. Others
        • 7.6.3.7.1. Market Trends and Opportunities
        • 7.6.3.7.2. Growth Prospects

8. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 8.1. Major Players and Strategy Analysis
  • 8.2. Market Share Analysis
  • 8.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 8.4. Competitive Dashboard

9. COMPANY PROFILES

  • 9.1. Roquette Freres Company
  • 9.2. Cargill, Incorporated.
  • 9.3. Ingredion Incorporated
  • 9.4. SPI Pharm
  • 9.5. Singsino Group Ltd.,
  • 9.6. Merck Millipore Corporation
  • 9.7. Bright Moon Seaweed